# Laura van ‘t Veer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laura-van-t-veer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 49,497 |
| Field | Breast Cancer Treatment Studies |
| h-index | 72 |
| i10-index | 167 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5014135109 |
| ORCID iD | https://orcid.org/0000-0002-9838-8298 |
| Works | 511 |

## Researcher papers

- [AACR Project GENIE: Powering Precision Medicine through an International Consortium](https://scholariq.org/papers/aacr-project-genie-powering-precision-medicine-through-an-international/)
- [The landscape of cancer genes and mutational processes in breast cancer](https://scholariq.org/papers/the-landscape-of-cancer-genes-and-mutational-processes-in-breast-cancer/)
- [Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies](https://scholariq.org/papers/associations-of-breast-cancer-risk-factors-with-tumor-subtypes-a-pooled-analysis/)
- [Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer](https://scholariq.org/papers/effect-of-pembrolizumab-plus-neoadjuvant-chemotherapy-on-pathologic-complete/)
- [Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer](https://scholariq.org/papers/adaptive-randomization-of-veliparib-carboplatin-treatment-in-breast-cancer/)
- [Adaptive Randomization of Neratinib in Early Breast Cancer](https://scholariq.org/papers/adaptive-randomization-of-neratinib-in-early-breast-cancer/)
- [Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival](https://scholariq.org/papers/circulating-tumor-dna-in-neoadjuvant-treated-breast-cancer-reflects-response-and/)
- [w4200350191](https://scholariq.org/papers/w4200350191/)
- [Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)](https://scholariq.org/papers/use-of-70-gene-signature-to-predict-prognosis-of-patients-with-node-negative/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.